Global Medical Publishing 2026-2030 Report
Medical publishing is evolving from a content-centered business into a market for digital tools, research services, and clinical workflow support. Simba Information analyzes the segments, demand indicators, competitors, and strategic pressures shaping market performance through 2030.
Free Sample Report
Request a free sample of this report and our team will email it to you.
Report Overview
The Next Growth Layer Is Built Around Medical Workflows
The next phase of medical publishing growth is increasingly tied to helping people discover, evaluate, and apply content— not simply expanding the volume available. This report examines how publishers are combining established medical content with AI, analytics, clinical tools, and research platforms while responding to open access, integrity concerns, and constrained institutional budgets.
Key Themes Covered in this Report:
- The shift from print and standalone content toward integrated clinical, education, and research workflows
- How open access, article processing charges, and research integrity are reshaping journal economics and strategy
- Publisher investment in AI, platform development, acquisitions, and integrity-screening tools
- Demand signals tied to R&D spending, research output, healthcare expenditures, and medical workforce growth
Key Questions Answered in the Report:
- Which product formats are positioned to gain or lose revenue through 2030?
- How are major publishers translating established medical content into higher-value tools and services?
- How will pricing resistance, research-integrity challenges, and macroeconomic pressure affect growth between 2026 and 2030?
- How do R&D investment, healthcare spending, research output, and medical workforce trends shape market opportunity?
Medical Publishing Growth Is Moving into the Workflow
Global medical publishing remains essential to the work of students, researchers, educators, clinicians, and other healthcare professionals, but the market is no longer defined only by journals and books. Publishers are increasingly competing through digital platforms, clinical reference tools, research services, and workflow solutions that help users discover, evaluate, and apply medical information. Simba Information estimates the market generated $10.9 billion in 2025 and will reach $12.1 billion in 2030, representing 2.1% average annual growth from 2025 to 2030.
Digital Products Provide the Clearest Growth Path
Journals remain the largest segment at $4.6 billion in 2025, while online content provides the stronger growth trajectory. Online content revenue reached $3.0 billion in 2025 and is forecast to grow 4.1% annually from 2025 to 2030 as publishers expand clinical decision support, drug information, research analytics, education tools, and AI-enabled services. Abstracting and indexing services also benefit from interface modernization and tools designed to improve research efficiency. By contrast, books continue their long-term decline as print contracts and more content is delivered through e-books, databases, and integrated digital platforms.
Trust, Access, and Affordability Shape Strategy
The forecast reflects a market balancing durable demand for medical knowledge with pressure on institutional budgets. Open access continues to expand publishing volume and author-funded revenue, but resistance to rising article processing charges and subscription prices increases the importance of transparent value and strong integrity controls. Research integrity has become a central operating issue, prompting publishers to invest in screening, verification, and editorial safeguards. Libraries, universities, hospitals, and health systems remain sensitive to price increases, making evidence of practical value and workflow impact increasingly important in purchasing decisions.
Scale Supports Investment, but Specialized Competitors Still Matter
The market is concentrated, led by Wolters Kluwer Health and Elsevier, which together generated more than one-quarter of publisher-level medical publishing revenue in 2025. Their scale supports sustained investment in platforms, data, and product development. The report also examines Springer Nature, Wiley, Hearst Health, EBSCO Information Services, AMBOSS, Merative, the American Medical Association, epocrates, OpenEvidence, NEJM Group, and other specialists. Company profiles connect product strategies with demand indicators such as research spending, healthcare expenditures, professional workforce growth, and regional infrastructure. The result is a human-centered view of how publishers are responding to the changing needs of the people and institutions that create, teach, and use medical knowledge.
Global Medical Publishing Report Details
| Current Total Market Size | $10.9 billion in 2025 |
| Forecast Total Market Growth Rate | 2.1% CAGR from 2025-2030 |
| Historical Period | 2020-2024 |
| Base Year | 2025 estimate |
| Forecast Period | 2026-2030 |
| Units Covered | Medical publishing revenue in millions of U.S. dollars; R&D and healthcare spending in constant 2024 U.S. dollars; professional headcounts in thousands |
| Regions | North America, Europe, Asia-Pacific, Rest of World |
| Selected Countries in Supporting Indicators | Selected countries appear in supporting R&D and economic outlook tables; the report does not provide country-level medical publishing market estimates |
| Products | Journals, online content, abstracting and indexing services, books, other activities |
| Demand Indicators | R&D spending, health sciences research output, healthcare expenditures, physician populations, nurse populations, dentist populations |
| Point Where Data is Measured | Publisher revenue; total market values are shown after elimination adjustments to reduce double counting |
| Additional Elements | 2025 regional distribution, leading publisher revenue, company strategy profiles, AI and platform development, mergers and acquisitions, open access, research integrity, institutional budgets, purchasing models, macroeconomic outlook |
Leading Companies Driving Trends in the Medical Publishing Industry
| AMBOSS | NEJM Group |
| American Medical Association | OpenEvidence |
| athenahealth/epocrates | Oxford University Press |
| EBSCO Information Services | Springer Nature |
| Elsevier | Taylor & Francis |
| Georg Thieme Verlag | Wiley |
| Hearst Health | Wolters Kluwer Health |
| Merative |
The Market Is Growing Around Use, Not Just Access
Medical publishers serve people working across the professional lifecycle: students learning foundational concepts, researchers producing new evidence, clinicians making time-sensitive decisions, and professionals maintaining current knowledge. Digital transformation has therefore moved beyond converting print into electronic formats. The strongest growth opportunities increasingly organize information around a task, whether that task is reviewing evidence, checking a drug interaction, preparing for an examination, teaching a clinical concept, or making a point-of-care decision.
Online Content Changes the Competitive Standard
Online content is the clearest growth opportunity because it allows publishers to combine proprietary information with search, analytics, decision support, education, and workflow functions. AI can improve discovery and workflow efficiency, but medical publishers must continue to support content quality, research integrity, and confidence in the underlying evidence. That combination places a premium on companies that can pair technology investment with established content and disciplined quality controls.
Open Access Creates Opportunity and Operational Pressure
Open access has expanded publishing options and increased the visibility of research, but it also changes who pays, how publication volume is managed, and where quality risks emerge. Publishers must balance access goals with sustainable economics, transparent pricing, and safeguards against manipulation. Research integrity is consequently becoming a product, editorial, and reputation issue rather than a narrow compliance function.
Institutional Value Must Be Demonstrable
Libraries, universities, hospitals, and health systems face persistent budget constraints even as their users expect more integrated and responsive information services. Under sustained institutional budget pressure, publishers will need to demonstrate the practical value of their platforms and content, including improved discoverability, workflow efficiency, and relevance to research, education, or clinical practice. The report connects these purchasing realities with publisher strategies, regional demand indicators, and the outlook for each major product format.
Demand Beyond Publishing Revenue
The report connects publishing performance with the systems that create and use medical knowledge, including R&D investment, health sciences research output, healthcare spending, and growth in physician, nurse, and dentist populations. These indicators provide a broader framework for evaluating regional demand and long-term opportunity.
Recommended Website Figure
Figure selection: Create a segment-growth comparison graphic using the direction of Table 5-4. Show online content as the strongest-growth major segment, abstracting and indexing as moderate growth, journals as modest growth, and books as declining. Omit full revenue values to preserve the report's proprietary detail.
Open access is changing journal funding, pricing, and publication volume, while AI is being integrated into discovery, clinical support, education, platform functions, and research-integrity screening.
The report covers professional medical journals, online clinical and research content, abstracting and indexing services, medical books, and conference and multimedia content serving healthcare students, researchers, educators, and professionals.
Online content is forecast to be the fastest-growing major segment, supported by clinical decision-support tools, research platforms, analytics, medical education products, and AI-enabled functionality.